Synergy in Dual Engagement of Extrinsic and Intrinsic Apoptosis Pathways by Bleomycin and Panobinostat in Hepatocellular Carcinoma and Targeting Mcl-1-Dependent Apoptosis Resistance

Patricia Mester, Lena Aschenbrenner, Vlad Pavel, Philipp Heumann, Elisabeth Aschenbrenner, Kirstin Pollinger, Karsten Gülow, Claudia Kunst, Tobias Schilling, Martina Müller

Open source

DOI
10.3390/biomedicines14081805
Published
2026-08-11
Container
Biomedicines
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14081805,
  title = {Synergy in Dual Engagement of Extrinsic and Intrinsic Apoptosis Pathways by Bleomycin and Panobinostat in Hepatocellular Carcinoma and Targeting Mcl-1-Dependent Apoptosis Resistance},
  author = {Patricia Mester and Lena Aschenbrenner and Vlad Pavel and Philipp Heumann and Elisabeth Aschenbrenner and Kirstin Pollinger and Karsten Gülow and Claudia Kunst and Tobias Schilling and Martina Müller},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14081805},
  url = {https://doi.org/10.3390/biomedicines14081805}
}

RIS

TY  - JOUR
TI  - Synergy in Dual Engagement of Extrinsic and Intrinsic Apoptosis Pathways by Bleomycin and Panobinostat in Hepatocellular Carcinoma and Targeting Mcl-1-Dependent Apoptosis Resistance
AU  - Patricia Mester
AU  - Lena Aschenbrenner
AU  - Vlad Pavel
AU  - Philipp Heumann
AU  - Elisabeth Aschenbrenner
AU  - Kirstin Pollinger
AU  - Karsten Gülow
AU  - Claudia Kunst
AU  - Tobias Schilling
AU  - Martina Müller
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14081805
UR  - https://doi.org/10.3390/biomedicines14081805
ER  - 

APA

Mester, P., Aschenbrenner, L., Pavel, V., Heumann, P., Aschenbrenner, E., Pollinger, K., Gülow, K., Kunst, C., Schilling, T., & Müller, M. (2026). Synergy in Dual Engagement of Extrinsic and Intrinsic Apoptosis Pathways by Bleomycin and Panobinostat in Hepatocellular Carcinoma and Targeting Mcl-1-Dependent Apoptosis Resistance. Biomedicines. https://doi.org/10.3390/biomedicines14081805

Source records